US2017086717A1PendingUtilityA1

Silicone based membranes for use in implantable glucose sensors

Assignee: DEXCOM INCPriority: May 22, 2002Filed: Dec 13, 2016Published: Mar 30, 2017
Est. expiryMay 22, 2022(expired)· nominal 20-yr term from priority
A61B 5/14532C08L 83/04A61B 5/14865C08G 77/12C08G 77/20A61B 5/6848C08G 77/46
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Membrane systems incorporating silicone polymers are described for use in implantable analyte sensors. Some layers of the membrane system may comprise a blend of a silicone polymer with a hydrophilic polymer, for example, a triblock poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) polymer. Such polymeric blends provide for both high oxygen solubility and aqueous analyte solubility.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An implantable continuous analyte sensor, comprising:
 a working electrode; and   a membrane system disposed over at least a portion of the working electrode, the membrane system comprising a first domain and a second domain, the first domain and the second domain each comprising a blend comprising a silicone-containing polymer and a hydrophilic polymer, the first domain having a blend ratio of silicone-containing polymer to hydrophilic polymer that is different than a blend ratio of silicone-containing polymer to hydrophilic polymer of the second domain.   
     
     
         2 . The implantable continuous analyte sensor of  claim 1 , wherein the first domain is less permeable to an interfering species than to an analyte. 
     
     
         3 . The implantable continuous analyte sensor of  claim 1 , wherein the first domain is configured to provide a greater reduction of transport of an interfering species therethrough than the second domain. 
     
     
         4 . An implantable continuous analyte sensor, comprising:
 a working electrode; and   a membrane disposed over the working electrode, the membrane comprising:
 a first domain configured to have a greater selectivity for reducing permeability therethrough of a first interfering species than a second interfering species; 
 a second domain configured to have a greater selectivity for reducing permeability therethrough of a second interfering species than a first interfering species; and 
 a third domain comprising an enzyme configured to react with an analyte; and 
 wherein the first and second interfering species are molecules that would be electro-reduced or electro-oxidized by the working electrode if they reached an electroactive surface the working electrode. 
   
     
     
         5 . The implantable continuous analyte sensor of  claim 4 , wherein the first domain comprises a blend comprising a silicone-containing polymer and a hydrophilic polymer. 
     
     
         6 . The implantable continuous analyte sensor of  claim 4 , wherein the second domain comprises ionic components configured to reduce a permeability of the second domain to the second interfering species. 
     
     
         7 . The implantable continuous analyte sensor of  claim 4 , wherein the first interfering species is acetaminophen, and wherein the second interfering species is ascorbic acid. 
     
     
         8 . A method of manufacturing a membrane for use in an analyte sensor, the method comprising:
 mixing a precursor of a silicone elastomer with a poly(ethylene oxide) and poly(propylene oxide) co-polymer; and   heating the mixture.   
     
     
         9 . The method of  claim 8 , wherein a ratio of co-polymer to silicone elastomer that is mixed is from about 1:20 w/w to about 1:4 w/w. 
     
     
         10 . The method of  claim 8 , further comprising mixing the co-polymer with a cross-linking agent. 
     
     
         11 . The method of  claim 10 , wherein the cross-linking agent is mixed with the co-polymer prior to mixing the co-polymer with the silicone elastomer precursor. 
     
     
         12 . The method of  claim 10 , wherein the cross-linking agent is selected from the group consisting of one or more of ethylene glycol diglycidyl ether and poly(ethylene glycol) diglycidyl ether. 
     
     
         13 . The method of  claim 10 , wherein the cross-linking agent comprises dicumyl peroxide. 
     
     
         14 . The method of  claim 10 , wherein the ratio of cross-linking agent to co-polymer is from about 10 cross-linking agent molecules per co-polymer molecule to about 30 cross-linking agent molecules per co-polymer molecule. 
     
     
         15 . The method of  claim 10 , wherein the amount of cross-linking agent added relative to the silicone elastomer and co-polymer is from about 0.5% to about 15% w/w. 
     
     
         16 . The method of  claim 10 , further comprising, after the mixing step but before the heating step, drawing the mixture into a thin film. 
     
     
         17 . The method of  claim 16 , further comprising, after the drawing the mixture into the thin film but before the heating the mixture, placing a piece of porous silicon on the thin film.

Join the waitlist — get patent alerts

Track US2017086717A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.